Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y Graham

Showing results (51-60 of 481) with videos related to

Pageof 49
Sort By:
Nature Clinical Practice. Gastroenterology & Hepatology|January 29, 2009
High-dose versus standard-dose PPI in triple therapy for Helicobacter pylori eradicationMitsushige Sugimoto, David Y Graham
JAMA|July 8, 2020
Stress Ulcer Prophylaxis for ICU PatientsAylin Tansel, David Y Graham
The Medical Clinics of North America|January 4, 2003
Pathogenesis and therapy of gastric and duodenal ulcer diseaseAkiko Shiotani, David Y Graham
Gastroenterology|May 23, 2012
Which Therapy for Helicobacter pylori Infection?David Y Graham, Akiko Shiotani
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|January 18, 2012
Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French breadDavid Y Graham, Hong Lu
Digestive Diseases and Sciences|February 11, 2020
Microbiome and Gastric CancerLars Engstrand, David Y Graham
Scandinavian Journal of Gastroenterology|July 23, 2005
Evidence-based examination of the African enigma in relation to Helicobacter pylori infectionAamer Agha, David Y Graham
Helicobacter|November 18, 2020
Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapyDavid Y Graham, Francis Megraud
Nature Clinical Practice. Gastroenterology & Hepatology|May 1, 2008
New concepts of resistance in the treatment of Helicobacter pylori infectionsDavid Y Graham, Akiko Shiotani
Expert Review of Gastroenterology & Hepatology|February 11, 2023
Response to: a true point-of-care molecular testing method for tailored therapy for <i>Helicobacter pylori</i> eradicationDavid Y Graham, Theodore Rokkas
Pageof 49

Showing results (51-60 of 481) with videos related to

Sort By:
Pageof 49
Nature Clinical Practice. Gastroenterology & Hepatology|January 29, 2009
High-dose versus standard-dose PPI in triple therapy for Helicobacter pylori eradicationMitsushige Sugimoto, David Y Graham
JAMA|July 8, 2020
Stress Ulcer Prophylaxis for ICU PatientsAylin Tansel, David Y Graham
The Medical Clinics of North America|January 4, 2003
Pathogenesis and therapy of gastric and duodenal ulcer diseaseAkiko Shiotani, David Y Graham
Gastroenterology|May 23, 2012
Which Therapy for Helicobacter pylori Infection?David Y Graham, Akiko Shiotani
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|January 18, 2012
Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French breadDavid Y Graham, Hong Lu
Digestive Diseases and Sciences|February 11, 2020
Microbiome and Gastric CancerLars Engstrand, David Y Graham
Scandinavian Journal of Gastroenterology|July 23, 2005
Evidence-based examination of the African enigma in relation to Helicobacter pylori infectionAamer Agha, David Y Graham
Helicobacter|November 18, 2020
Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapyDavid Y Graham, Francis Megraud
Nature Clinical Practice. Gastroenterology & Hepatology|May 1, 2008
New concepts of resistance in the treatment of Helicobacter pylori infectionsDavid Y Graham, Akiko Shiotani
Expert Review of Gastroenterology & Hepatology|February 11, 2023
Response to: a true point-of-care molecular testing method for tailored therapy for <i>Helicobacter pylori</i> eradicationDavid Y Graham, Theodore Rokkas
Pageof 49